NASDAQ:FOLD - Nasdaq - US03152W1099 - Common Stock - Currency: USD
FOLD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 567 industry peers in the Biotechnology industry. While FOLD is still in line with the averages on profitability rating, there are concerns on its financial health. FOLD is valued quite expensive, but it does show an excellent growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -7.15% | ||
ROE | -28.91% | ||
ROIC | 4.23% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 6.45% | ||
PM (TTM) | N/A | ||
GM | 89.98% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 2.01 | ||
Debt/FCF | N/A | ||
Altman-Z | -1.28 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.39 | ||
Quick Ratio | 2.6 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 223.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 54.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
7.35
+0.15 (+2.08%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 223.65 | ||
P/S | 4.27 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 11.64 | ||
P/tB | N/A | ||
EV/EBITDA | 54.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -7.15% | ||
ROE | -28.91% | ||
ROCE | 5.35% | ||
ROIC | 4.23% | ||
ROICexc | 6.96% | ||
ROICexgc | 15.7% | ||
OM | 6.45% | ||
PM (TTM) | N/A | ||
GM | 89.98% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 2.01 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 9.16 | ||
Cap/Depr | 41.57% | ||
Cap/Sales | 0.67% | ||
Interest Coverage | 0.58 | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 3.39 | ||
Quick Ratio | 2.6 | ||
Altman-Z | -1.28 |